Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Welichem Biotech's antipsoriatic drug candidate enters phase I clinical trial

Aug. 13, 2007

Astion's ASF-1096 recommended orphan drug status by EMEA

Aug. 6, 2007

CMD defers marketing authorization decision of Oracea to CHMP

Aug. 2, 2007

New treatment options for dermatological disorders divulged in recent patent

Aug. 1, 2007

Patient recruitment completed for Isotechnika's pivotal phase III psoriasis trial

July 26, 2007

FDA accepts QLT's labeling sNDA for Aczone

July 25, 2007

Positive interim results from Peplin's phase IIb study of PEP-005 for AK

July 24, 2007

ProMetic BioSciences and Darier to codevelop PBI-1308

July 19, 2007

BioCryst and Roche to begin phase II study of BCX-4208 for psoriasis

July 19, 2007

Extina Foam approved for seborrheic dermatitis

July 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...